Accustem Sciences Inc. financial data

Symbol
ACUT on OTC
Location
New York, NY
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2025 - 12 Nov 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 30% % 720%
Debt-to-equity -144% % -38%
Return On Equity 59% % 16%
Return On Assets -135% % 90%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 16,072,267 shares 42%
Common Stock, Shares, Outstanding 16,072,267 shares 42%
Entity Public Float $2,179,335 USD -86%
Common Stock, Value, Issued $16,072 USD 42%
Weighted Average Number of Shares Outstanding, Basic 16,072,267 shares 42%
Weighted Average Number of Shares Outstanding, Diluted 16,072,267 shares 42%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense $203,242 USD 9.3%
General and Administrative Expense $1,410,567 USD 18%
Operating Income (Loss) $1,613,809 USD -17%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $1,613,809 USD -17%
Net Income (Loss) Attributable to Parent $1,613,809 USD -17%
Earnings Per Share, Basic 0 USD/shares 23%
Earnings Per Share, Diluted 0 USD/shares 23%

Balance Sheet

Label TTM Value / Value Unit Change %
Other Assets, Current $1,500,000 USD
Assets, Current $1,573,247 USD 1435%
Property, Plant and Equipment, Net $105 USD -97%
Assets $1,573,247 USD 1415%
Accounts Payable, Current $923,191 USD 17%
Accrued Liabilities, Current $149,774 USD -8.7%
Liabilities, Current $4,484,157 USD 36%
Liabilities $4,484,157 USD 36%
Retained Earnings (Accumulated Deficit) $9,268,755 USD -21%
Stockholders' Equity Attributable to Parent $2,910,910 USD 8.9%
Liabilities and Equity $1,573,247 USD 1415%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $290,182 USD -22%
Net Cash Provided by (Used in) Financing Activities $321,517 USD 43%
Common Stock, Shares Authorized 150,000,000 shares 0%
Common Stock, Shares, Issued 16,072,267 shares 42%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $31,335 USD
Interest Paid, Excluding Capitalized Interest, Operating Activities $336 USD -52%
Deferred Tax Assets, Valuation Allowance $1,739,581 USD 28%
Depreciation $1,326 USD -63%
Property, Plant and Equipment, Gross $10,999 USD 0%
Deferred Tax Assets, Operating Loss Carryforwards $1,592,349 USD 29%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10,000,000 shares 0%
Additional Paid in Capital $6,341,773 USD 43%
Preferred Stock, Shares Outstanding 0 shares
Deferred Tax Assets, Net of Valuation Allowance $1,739,581 USD 28%
Share-based Payment Arrangement, Expense $0 USD
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%